Biogen Idec Inc

(NASDAQ:BIIB)

41.43

+2.41 (6.18%)

Dec 02 - Close

Open
39.61
High
41.60
Low
39.31
Vol.
3.53M
Mkt Cap
11.38B
52Wk High
78.57
52Wk Low
37.21
Avg. Vol.
3.58M
P/E (Trailing)
15.99
Beta
0.76
Short %
2.70%
Div. Yield
—

After-Hours 42.35 +0.92 (2.22%) Tue, 2 Dec 2008 7:40 PM

Company Profile

Biogen Idec Inc

14 Cambridge Center

Cambridge, MA 02142

United States - Map

Phone: (617) 679-2000

Fax: (617) 679-2617

Website: www.biogenidec.com

State of incorporation: Delaware

CEO: James C. Mullen

Employees: 4,300

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Dev immunologically active monoclonal antibodies

A biotechnology company, which is engaged in the development, manufacturing and commercialization of therapies.

Recent news for BIIB

Recent opinions on BIIB

No recent Opinions for BIIB

Top members owning BIIB

Members owning BIIB also own

ELN (50.00%), PCAR (25.00%), CLNE (25.00%), WYE (25.00%), IPHS (25.00%)

Member sentiment: Sell